# Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer

> **NCT00233389** · PHASE4 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 301 (actual)

## Conditions studied

- Stomach Ulcer

## Interventions

- **DRUG:** Rebamipide

## Key facts

- **NCT ID:** NCT00233389
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04-30
- **Primary completion:** 2005-09-01
- **Final completion:** 2005-09-09
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2021-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233389, "Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00233389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*